A recent study using the 5XFAD mouse model with PLX5622, a specific colony-stimulating factor 1 receptor inhibitor that allows for the sustained and specific elimination of microglia [71], was conducted to determine whether microglial depletion influences AD pathology [72]. Here, CSF1R is linked to Alzheimer disease.